Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy | Molecular Cancer | Full Text
PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer | PNAS
Identification and Validation of a PD-L1 Binding Peptide for Determination of PDL1 Expression in Tumors | Scientific Reports
Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation - Pathology
Release the B7.1! Anti-PD-L1 breaks PD-L1's grip
Tumor cell-intrinsic PD-1 receptor is a tumor suppressor and mediates resistance to PD-1 blockade therapy | PNAS
Phosphorylation of PD-1-Y248 is a marker of PD-1-mediated inhibitory function in human T cells | Scientific Reports
Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion | Nature Communications
IRF-1 as a predictive marker for anti-PD-1 therapy. a IRF-1 expression... | Download Scientific Diagram
Anti-PDL-1 Antibody Treatment Reduces Expression of the Exhaustion Marker PD -1 in T Cells | Biocompare Antibody Review
High IL-8 correlates with reduced response to PD-1/PD-L1 checkpoint blockade
Cancer immunotherapy and the PD-1/PD-L1 checkpoint pathway | Abcam
Effect of blocking PD-1 and PD-L1 on immune checkpoint and Treg-related... | Download Scientific Diagram
Emerging biomarkers as predictors to anti-PD1/PD-L1 therapies in advanced melanoma | Immunotherapy
Learning from PD-1 Resistance: New Combination Strategies: Trends in Molecular Medicine
Frontiers | PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
Raji-hPD-1 cells | ADCC targets | InvivoGen
Biomarkers of response to PD-1 pathway blockade | British Journal of Cancer
Frontiers | Tumor-Infiltrating PD-1hiCD8+-T-Cell Signature as an Effective Biomarker for Immune Checkpoint Inhibitor Therapy Response Across Multiple Cancers
CD72/CD100 and PD-1/PD-L1 markers are increased on T and B cells in HIV-1+ viremic individuals, and CD72/CD100 axis is correlated with T-cell exhaustion | PLOS ONE
PD-1/ PD-L1 blockade as a novel treatment for colorectal cancer - ScienceDirect
IVD Antibody Development Services for PD-L1 Marker - Creative Biolabs
Predictive Markers for the Efficacy of Anti–PD-1/PD-L1 Antibodies in Lung Cancer - ScienceDirect
Predictive biomarkers in PD-1/PD-L1 checkpoint blockade immunotherapy - ScienceDirect
Frontiers | The Diverse Function of PD-1/PD-L Pathway Beyond Cancer
Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy | Molecular Cancer | Full Text
